NAD+ Precursors: Reading the Trial Evidence and Answering the Patient Who Asks

Why the NAD+ pool falls with age is a consumption problem, not a production failure — and why that reframes every question about NR, NMN and intravenous NAD. What the human trials actually measured, what they did not, and how to answer the patient holding the bottle.